Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: JACC Heart Fail. 2022 Mar 9;10(4):266–275. doi: 10.1016/j.jchf.2021.12.004

Figure 2: Association of Frailty status at baseline with the probability of achieving optimal guideline directed medical therapy regimen (triple therapy or double therapy).

Figure 2:

Non-frail participants (FI Class I) were significantly more likely to be started on the optimal GDMT triple therapy (A) and double therapy (B) over the study period compared with those with high frailty burden (FI Class III).